Skip to main content
Clinical Trials/NCT03605914
NCT03605914
Completed
Phase 4

Are NSAIDs Effective Enough for Postoperative Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty

The University of Texas Health Science Center, Houston1 site in 1 country100 target enrollmentAugust 1, 2018

Overview

Phase
Phase 4
Intervention
diclofenac
Conditions
Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
100
Locations
1
Primary Endpoint
Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to compare the level of pain control in patients receiving non-steroidal anti-inflammatory drugs (NSAIDs) to those receiving opioids in the postoperative period after endoscopic sinus surgery (ESS) and/or septoplasty.

Registry
clinicaltrials.gov
Start Date
August 1, 2018
End Date
July 5, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Martin J Citardi, MD

Professor and Chairman, Department of Otorhinolaryngology - Head and Neck Surgery

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • english speaking
  • candidates for endoscopic sinus surgery as determined by medical necessity by the treating rhinologist
  • scheduled for surgery at Texas Sinus Institute

Exclusion Criteria

  • allergy to either NSAIDs or opioids
  • contraindication to NSAIDs (ex. gastritis, chronic kidney disease)
  • surgical plan exceeding basic endoscopic sinus surgery
  • use of anticoagulation
  • the presence of any pain disorder
  • the current usage of any analgesic medication
  • history of opioid addiction
  • pregnancy
  • history of chronic pain or fibromyalgia
  • current daily use of NSAIDs, acetaminophen, opioids or other analgesics (pregabalin, tramadol, etc)

Arms & Interventions

NSAID

The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.

Intervention: diclofenac

opioid

The Opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).

Intervention: Norco

Outcomes

Primary Outcomes

Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)

Time Frame: 24 hours (day 1 after operation)

The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.

Secondary Outcomes

  • Number of Participants With Constipation(5 days after operation)
  • Number of Participants With Nausea or Vomiting(5 days after operation)
  • Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)(120 hours (day 5 after operation))
  • Number of Participants With Bleeding Complications(5 days after operation)

Study Sites (1)

Loading locations...

Similar Trials